Korea flags 36 penny stocks under tougher delisting rules
South Korea’s Korea Exchange flagged 36 penny stocks for administrative issues under tougher delisting rules, including 9 KOSPI and 27 KOSDAQ names. Stocks qualify if price stays below 1,000 won for 30 days or market cap stays under thresholds. Delisting proceedings start after failure to recover for 45 days. Affected firms include CMG Pharma, LabGenomics, JMI, and Daeyoung Packaging.
How this was made
The 30-second read
Why it matters
The designation process is rule-based: stocks below 1,000 won (or below market-cap thresholds) for 30 consecutive sessions are flagged, then delisting proceedings begin if they fail to recover above the threshold for 45 consecutive sessions during a 90-day recovery period. The article also notes market-cap thresholds will rise next year, increasing forward compliance pressure.
Market read
This is a concrete regulatory action that increases delisting risk for specific microcaps and can drive near-term volatility and defensive corporate actions, while also potentially improving Kosdaq earnings and valuation metrics.
What to watch
Court injunction attempts and the upcoming tiered Kosdaq segmentation (Premium/Standard) could change investor perception and liquidity, offsetting some delisting-risk discount.
Background
South Korea’s KRX and Financial Services Commission introduced reforms to accelerate exits of distressed and marginal companies, including new administrative-issue triggers based on sustained low price or market cap.
Ticker impact
CMG Pharma was named among 36 companies flagged as administrative issues under new, tougher penny-stock delisting thresholds.
Downward bias and higher volatility while investors price delisting probability.
The article states CMG Pharma is included in the administrative-issue list tied to specific price and market-cap tests, which typically raises risk premia.
Market effects
Tougher delisting mechanics can reduce the pool of marginal issuers, potentially improving Kosdaq aggregate earnings and compressing valuation multiples.
Korea’s junior market may see rotation away from penny-stock risk toward higher-quality names as administrative-issue lists expand.
Limited direct global impact, but it can influence international flows into Korea’s small-cap and emerging-market risk buckets.
Counterpoint
Administrative-issue designations may already be priced in for the most distressed names, so the marginal impact could be smaller than expected if many firms execute share consolidations quickly.
Key entities
- regulator/exchangeKorea Exchange (KRX)
Designated 36 listed companies as administrative issues under tougher delisting rules.
- regulatorFinancial Services Commission (FSC)
Announced reforms with the KRX to speed removal of penny stocks and financially weak firms.
- companyCMG Pharma
Kosdaq-listed company flagged as an administrative issue.
- companyLabGenomics
Kosdaq-listed company flagged as an administrative issue.
- companyJMI
Kosdaq-listed company flagged and announced a five-for-one share consolidation.
